Jacobson Center for Clinical & Translational Research

Main Menu


Additional Information


Contact Us

Huntington Disease

Study Title:   A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo Controlled Study in Subjects with Late Prodromal and Early Manifest Huntington's Disease (HD) to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of VX15/2503 (SIGNAL).  (Identifier NCT0241674)

Study Purpose:  The purpose of this study is to evaluate the safety, tolerability, PK, and efficacy of VX15/2503 in subjects with late prodromal and early manifest Huntington's disease.

Principal Investigator: Lawrence Elmer, MD

Study Coordinator:  For more information email Stephanie Wilson, RN, or call 419.383.6721

Last Updated: 1/31/19